Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function

Description

This is a pilot study to assess using validated outcome measures how ingesting pumpkin seed oil extract supports patient bladder function in a United States population.

Conditions

Overactive Bladder (OAB)

Study Overview

Study Details

Study overview

This is a pilot study to assess using validated outcome measures how ingesting pumpkin seed oil extract supports patient bladder function in a United States population.

Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function

Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function

Condition
Overactive Bladder (OAB)
Intervention / Treatment

-

Contacts and Locations

Chicago

Northwestern University, Chicago, Illinois, United States, 60611

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All patients evaluated at Northwestern's IPHP who report bladder function consistent with overactive bladder (urinary urgency, with or without urinary frequency more than 8 times daily or nocturia, with or without urgency urinary incontinence) at their index visit, who are also willing to use a dietary supplement and not initiate additional behavioral, medication or procedural treatment for 12 weeks following pumpkin seed oil extract initiation.
  • * Patients with any of the following will be excluded from the study:
  • * Use of other supplements that contain pumpkin seed oil
  • * ≥Stage 3 pelvic organ prolapse
  • * Urinary post-void residual ≥150cc
  • * Culture-proven urinary tract infection at time of study enrollment
  • * Recurrent urinary tract infection
  • * Neurogenic bladder
  • * Abdominal or pelvic malignancy
  • * Initiation of new overactive bladder medications or supplements during study period or in the 3 months immediately preceding study enrollment
  • * History of surgery in the past 12 months for pelvic organ prolapse, stress urinary incontinence, urgency urinary incontinence, or fecal or flatal incontinence
  • * Patient's primary language is not English

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Northwestern University,

Study Record Dates

2026-07-01